Friederike Schaub
Papers
1
Total Citations
12
H-Index
1
About
Friederike Schaub is a leading ophthalmology researcher whose work centers on innovative treatments for uveal melanoma, a rare but aggressive eye cancer. Her most-cited paper, "CyberKnife®: Eine neue Therapieoption bei uvealem Melanom" (2017, 12 citations), introduces a groundbreaking, non-invasive radiation therapy alternative to traditional enucleation or plaque brachytherapy. This study demonstrates how CyberKnife radiosurgery precisely targets tumors while sparing healthy ocular tissue, offering patients improved vision preservation and quality of life. Schaub’s contributions bridge the gap between advanced radiation oncology and ophthalmic surgery, establishing a new standard of care for this challenging malignancy. Her work has been instrumental in expanding treatment options, particularly for patients with large or unresectable tumors. With a growing citation impact, Schaub continues to shape clinical protocols and inspire further research into stereotactic radiosurgery for ocular cancers. Her dedication to patient-centered innovation and interdisciplinary collaboration marks her as a rising authority in ocular oncology.
Research Focus
Key Achievements
Top Papers
- 1CyberKnife®: Eine neue Therapieoption bei uvealem Melanom12 citations · 2017